Table 2 Main outcomes of matched patients whether or not they received selective digestive decontamination

Ouctomes

Candidemia

31 (0.5)

23 (0.8)

8 (0.3)

Sources of candidemia^a

Catheter

9 (29.0)

7 (30.4)

2 (25.0)

Digestive

6 (19.3)

5 (21.7)

1 (12.5)

Other or unknown

14 (45.2)

10 (43.5)

4 (50.0)

Pleuro-pulmonary site

1 (3.2)

1 (4.3)

0 (0.0)

Skin

1 (3.2)

0 (0.0)

1 (12.5)

Candida species isolated

Candida albicans

21 (67.7)

16 (69.6)

5 (62.5)

Candida glabrata

3 (9.7)

3 (13.0)

0 (0.0)

Candida parapsilosis

1 (3.2)

1 (4.3)

0 (0.0)

Candida tropicalis

2 (6.4)

2 (8.7)

0 (0.0)

Candida krusei

2 (6.4)

1 (4.3)

1 (12.5)

Other Candida species

2 (6.4)

0 (0.0)

2 (25.0)

MDR bacteria acquisition^b

103 (2.9)

82 (4.6)

21 (1.2)

ICU length of stay (days)

9 [5–18]

9 [5–18]

9 [5–17]

Duration of mechanical ventilation (days)

6 [3–12]

6 [3–12]

6 [3–21]

ICU case fatality

1821 (31.1)

908 (31.0)

913 (31.1)